| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| I Anghelescu, A Szegedi, S Schlegel, H Weigmann, C Hiemke, H Wetze. Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 8. issue 4. 1999-04-13. PMID:9928923. |
combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial. |
1999-04-13 |
2023-08-12 |
Not clear |
| C A Galletly, C R Clark, A C McFarlane, D L Webe. Effects of clozapine for non-treatment-resistant patients with schizophrenia. Psychiatric services (Washington, D.C.). vol 50. issue 1. 1999-04-07. PMID:9890589. |
effects of clozapine for non-treatment-resistant patients with schizophrenia. |
1999-04-07 |
2023-08-12 |
Not clear |
| C A Galletly, C R Clark, A C McFarlane, D L Webe. Effects of clozapine for non-treatment-resistant patients with schizophrenia. Psychiatric services (Washington, D.C.). vol 50. issue 1. 1999-04-07. PMID:9890589. |
in this study clozapine was given to 19 patients with schizophrenia who did not meet these criteria and whose symptoms were mild to moderate in severity. |
1999-04-07 |
2023-08-12 |
Not clear |
| M Biondi, L Fedele, T Arcangeli, P Pancher. Development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine. Psychotherapy and psychosomatics. vol 68. issue 2. 1999-03-29. PMID:10026463. |
development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine. |
1999-03-29 |
2023-08-12 |
Not clear |
| A J Jenkins, K M Sarconi, H N Raa. Determination of olanzapine in a postmortem case. Journal of analytical toxicology. vol 22. issue 7. 1999-03-24. PMID:9847013. |
it is structurally similar to clozapine, has a low incidence of extrapyramidal effects, and is effective in treating both the positive and negative symptoms of schizophrenia. |
1999-03-24 |
2023-08-12 |
Not clear |
| N Blieden, S Flinders, K Hawkins, M Reid, L D Alphs, C L Arfke. Health status and health care costs for publicly funded patients with schizophrenia started on clozapine. Psychiatric services (Washington, D.C.). vol 49. issue 12. 1999-03-22. PMID:9856622. |
health status and health care costs for publicly funded patients with schizophrenia started on clozapine. |
1999-03-22 |
2023-08-12 |
Not clear |
| N Blieden, S Flinders, K Hawkins, M Reid, L D Alphs, C L Arfke. Health status and health care costs for publicly funded patients with schizophrenia started on clozapine. Psychiatric services (Washington, D.C.). vol 49. issue 12. 1999-03-22. PMID:9856622. |
the study examined the effect of clozapine treatment on the health care costs and health status of people with schizophrenia who are supported by public funds. |
1999-03-22 |
2023-08-12 |
Not clear |
| M Fin. ECT and clozapine in schizophrenia. The journal of ECT. vol 14. issue 4. 1999-03-17. PMID:9871841. |
ect and clozapine in schizophrenia. |
1999-03-17 |
2023-08-12 |
Not clear |
| S C Bhatia, S K Bhatia, S Gupt. Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia. The journal of ECT. vol 14. issue 4. 1999-03-17. PMID:9871852. |
concurrent administration of clozapine and ect: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia. |
1999-03-17 |
2023-08-12 |
Not clear |
| A Vysokanov, J Flores-Hernandez, D J Surmeie. mRNAs for clozapine-sensitive receptors co-localize in rat prefrontal cortex neurons. Neuroscience letters. vol 258. issue 3. 1999-03-15. PMID:9885960. |
the clinical efficacy of clozapine in treating schizophrenia may stem from its lack of receptor selectivity. |
1999-03-15 |
2023-08-12 |
rat |
| E Howanitz, M Pardo, D A Smelson, C Engelhart, N Eisenstein, R G Stern, M F Losoncz. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. The Journal of clinical psychiatry. vol 60. issue 1. 1999-03-15. PMID:10074877. |
the efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. |
1999-03-15 |
2023-08-12 |
Not clear |
| E Howanitz, M Pardo, D A Smelson, C Engelhart, N Eisenstein, R G Stern, M F Losoncz. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. The Journal of clinical psychiatry. vol 60. issue 1. 1999-03-15. PMID:10074877. |
therefore, we conducted a 12-week double-blind comparison study to assess the efficacy and tolerability of clozapine and chlorpromazine in a group of elderly inpatients with chronic schizophrenia. |
1999-03-15 |
2023-08-12 |
Not clear |
| P F Buckle. New antipsychotic agents: emerging clinical profiles. The Journal of clinical psychiatry. vol 60 Suppl 1. 1999-03-02. PMID:10037165. |
clozapine has an established role in treatment-resistant schizophrenia. |
1999-03-02 |
2023-08-12 |
Not clear |
| R W Buckman, R D Mala. Clozapine for refractory schizophrenia: the Illinois experience. The Journal of clinical psychiatry. vol 60 Suppl 1. 1999-03-02. PMID:10037166. |
clozapine for refractory schizophrenia: the illinois experience. |
1999-03-02 |
2023-08-12 |
Not clear |
| R W Buckman, R D Mala. Clozapine for refractory schizophrenia: the Illinois experience. The Journal of clinical psychiatry. vol 60 Suppl 1. 1999-03-02. PMID:10037166. |
based upon the illinois department of mental health and developmental disabilities' computerized clinical information system, with its integration of client-specific clinical data, a 5-year retrospective study was designed to determine the clinical effectiveness and economic impact of the use of clozapine for treatment-resistant schizophrenia. |
1999-03-02 |
2023-08-12 |
Not clear |
| W H Rei. New vs. old antipsychotics: the Texas experience. The Journal of clinical psychiatry. vol 60 Suppl 1. 1999-03-02. PMID:10037167. |
a study was conducted in texas state psychiatric facilities of 299 patients with schizophrenia who were taking clozapine, comparing them with 223 matched controls taking traditional neuroleptics. |
1999-03-02 |
2023-08-12 |
Not clear |
| W H Rei. New vs. old antipsychotics: the Texas experience. The Journal of clinical psychiatry. vol 60 Suppl 1. 1999-03-02. PMID:10037167. |
in a separate study, clozapine therapy was shown to produce a 5-fold decrease in the rate of suicide among patients with schizophrenia. |
1999-03-02 |
2023-08-12 |
Not clear |
| W H Rei. New vs. old antipsychotics: the Texas experience. The Journal of clinical psychiatry. vol 60 Suppl 1. 1999-03-02. PMID:10037167. |
administration of clozapine appears to lower the overall cost of treating schizophrenia by reducing the costs associated with hospitalizations. |
1999-03-02 |
2023-08-12 |
Not clear |
| R J Wyatt, F Karoum, J Masseran. Effects of antipsychotics, vitamin E, and MK-801 on dopamine dynamics in the rat brain following discontinuation of cocaine. Psychiatry research. vol 80. issue 3. 1999-02-25. PMID:9796937. |
in addition to the potential value these findings have for further understanding cocaine abuse, it is proposed that the alteration in dopamine metabolism produced by cocaine, and the ability of haloperidol, clozapine and vitamin e to decrease cocaine's effects, model some biochemical aspects of schizophrenia. |
1999-02-25 |
2023-08-12 |
rat |
| S Kapur, R B Zipursky, G Remingto. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. The American journal of psychiatry. vol 156. issue 2. 1999-02-25. PMID:9989565. |
clinical and theoretical implications of 5-ht2 and d2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. |
1999-02-25 |
2023-08-12 |
Not clear |